Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Why this molecule is studied Why researchers study these two
GLP-1 receptor agonists reduce body weight by decreasing food intake, improving insulin sensitivity as well as delaying gastric emptying
Patients on any oral antihyperglycemic agent in monotherapy (N=212) or on a PPAR agent in combination therapy (N=106) or not on an antihyperglycemic agent (off therapy for at least 8 weeks, N=34) were switched to monotherapy with pioglitazone (at a dose of 30-45 mg per day), and completed a run-in period of approximately 12 weeks in duration
Inhibition of miR-200c restores endothelial function in diabetic mice through suppression of COX-2
Funding The ReCePI study is funded by a contract with the US Department of Health and Human Services, Biomedical Advanced Research and Development Authority (HHS010020160009c) with Cerus Corporation
12:S74- S79 (2000)
US$ 29.21
US$ 26.28
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
US$ 20.54
US$ 20.67
